The decision to move the field trials to Grifith University in Brisbane (away from the Cleanaway sight) is certainly positive for the company, and probably should have been the preferred site from the outset, in my opinion. Monitoring and data collection is vital here, and it is far more efficient to have the program under the watch of Dr Chris Pratt and his team at Grifith than at one of Cleanaway's out of the way waste dumps. The monitoring of emission and oxidisation will be conducted multiple times daily, this will of course enable a much deeper and commercially viable data set. I would also think that since the program is not on Cleanaway real estate, other waste dump operators (and potential investors) could be invited onsite to witness the infill trials first hand.
The already validated technology demonstrates that the company's Zeotech4 product oxidises 70/80% of emissions via a biological process, a further 15% is oxidised via a chemical process wherein the Zeotech4 product acts as a catalyst in that chemical process.
This a viable solution to an out of control global problem. Data from infill trials will shortly be available in final validation.
Add to My Watchlist
What is My Watchlist?
